Skin Irritation Potential Research Articles

Retinol-Loaded Deep Eutectic Solvent emulsion: Improved Stability and Therapeutic Efficiency

Retinol is used to manage epidermal and keratin metabolism, promote collagen formation, erase wrinkles for firmer skin, and restore suppleness and smoothness. Retinol can be difficult to store and use owing to the potential for skin irritation, oxidation, and biological ineffectiveness. The linolenic acid and phosphatidylcholine deep eutectic solvent (DES) had a low melting point, high bioactivity, and integrated capsule technology for retinol encapsulation. Safety evaluation tests revealed that the formulated DES-retinol emulsion was less cytotoxic than free retinol, as well as less irritant toward chicken embryos, pig skin, and human patches. In a keratinocyte inflammatory factor inhibition assay, the DES-retinol emulsion reduced monocyte chemoattractant protein-1 expression, indicating the potential to reduce the inflammatory response of the skin to retinol-induced irritation. The DES-retinol emulsion exhibited pro-permeability, anti-wrinkle, firming, and antioxidant characteristics in cellular, skin, and clinical investigations. The DES-retinol emulsion promoted type I collagen production, suppressed matrix metalloproteinase-1 activity, and reduced the release of reactive oxygen species. Consequently, the quantity, size, and depth of wrinkles were substantially improved, along with an enhanced anti-aging effect, heightened skin hydration, increased collagen intensity and flexibility, and diminished retinol-induced irritation. In conclusion, the retinol-loaded linolenic acid and phosphatidylcholine DES emulsion exhibited improved stability, enhanced transdermal efficiency, and notable therapeutic effects.

Microscopic Origin of Surfactant Irritation: An Experimental and Computational Study.

Surfactants, which are widely used in skin care products and cleansers, can cause skin irritation. The skin irritation potential of surfactants is fundamentally determined by their molecular structure and is directly related to their microscopic aggregation structure and specific interactions with the skin. The microscopic origin of the irritation of the surfactants remains unknown. In this work, irritation properties of four surfactant solutions were measured, and their microscopic aggregation behavior was systematically analyzed. The results indicate that the surfactants self-assembled in aqueous solution to form aggregates with different morphologies, where the head groups of surfactants were closer to each other. Furthermore, surfactants that can form larger and more stable aggregate structures in aqueous solutions will exhibit less irritation. These findings hold significant implications for the design and expanded applications of mild surfactants.

Prolonged Skin Retention of Luliconazole from SLNs Based Topical Gel Formulation Contributing to Ameliorated Antifungal Activity.

The development of effective therapy is necessary because the patients have to contend with long-termtherapy as skin fungal infections usually relapse and are hardly treated. Despite being a potent antifungal agent, luliconazole (LCZ) has certainshortcomings such as limited skin penetration, low solubility in aqueous medium, and poor skin retention. Solid Lipid Nanoparticles (SLNs) were developed using biodegradable lipids by solvent injection method and were embodied into the gel base for topical administration. After in-vitro characterizations of the formulations, molecular interactions of the drug with excipients were analyzed using in-silico studies. Ex-vivo release was determined in contrast to the pure LCZ and the commercial formulation followed by in-vivo skin localization, skin irritation index, and antifungal activity. The prepared SLNs have an average particle size of 290.7nm with no aggregation of particles and homogenous gels containing SLNs with ideal rheology and smooth texture properties were successfully prepared. The ex-vivo LCZ release from the SLN gel was lower than the commercial formulation whereas its skin deposition and skin retention were higher as accessed by CLSM studies. The drug reaching the systemic circulation and the skin irritation potential were found to be negligible. Thesolubility and drug retention in the skin were both enhanced by the development of SLNs as a carrier. Thus, SLNs offer significant advantages by delivering long lasting concentrations of LCZ at the site of infection for a complete cure of the fungal load together with skin localization of the topical antifungal drug.

Safety and efficacy of a feed additive consisting of Saccharomyces cerevisiae NCYC R618 (Benesacc®) for chickens for fattening and other poultry species for fattening and reared for laying (Global Nutritech Biyoteknoloji Ltd. Sti).

Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of Saccharomyces cerevisiae NCYC R618 as a zootechnical feed additive (functional group: gut flora stabiliser) for chickens for fattening and other poultry species for fattening and reared for laying. The additive has never been authorised. The strain under assessment S. cerevisiae (NCYC R618) qualifies for the qualified presumption of safety (QPS) and, consequently, the FEEDAP Panel concluded that the product is safe for the target species, the consumers and the environment. The FEEDAP Panel could not conclude on the skin and eye irritation or skin sensitisation potential of the additive. The additive should be considered a respiratory sensitiser. Due to the lack of sufficient data, the Panel cannot conclude on the efficacy of the additive under the proposed conditions of use.

Inhibitory Effects of Polyphenols from Equisetum ramosissimum and Moringa peregrina Extracts on Staphylococcus aureus, Collagenase, and Tyrosinase Enzymes: In vitro Studies

Background: Skin problems caused by oxidative stress lead to the activation of collagenase and tyrosinase enzymes, contributing to skin aging, discoloration, and infections. Equisetum ramosissimum and Moringa peregrina were assessed for their potential uses in treating various skin conditions. Objective: The present research aimed to investigate the positive effects of polyphenols in Equisetum ramosissimum and Moringa peregrina extracts as potential cosmetic products for the treatment of different skin conditions. Methods: Total phenolic and flavonoid contents, antioxidants, and anti-collagenase and anti-tyrosinase activities of plant extract mixtures (PEM) at different ratios of (M. peregrina: E. ramosissimum) were determined using standard procedures. Inhibitory effects of PEM against acne-causing Staphylococcus aureus (ATCC 29213) were evaluated using the diameter (cm) of the inhibition zone method. A cream formulation containing PEM was developed and characterized for stability and potential skin irritation in rats using standard procedures. Results: The PEM at a ratio of (2:1) showed the highest total phenolic and flavonoid content (150.15 ± 2.8 mg/g, equivalent to gallic acid, and 41.5 ± 1.2 mg/g, equivalent to quercetin, respectively). Antioxidant activities for PEM (2:1) were also optimal, as determined by the DPPH and ABTS methods (IC50 = 7.06 ± 0.12 µg/mL and 53.29 ± 3.3 µg/mL, respectively). Furthermore, PEM (2:1) exhibited superior inhibitory activities against collagenase and tyrosinase enzymes (IC50 = 32.4 ± 1.19 µg/mL and 8.4 ± 1.19 µg/mL, respectively). Antimicrobial activity of PEM (2:1) tested on S. aureus showed the largest zone of growth inhibition (2.8 cm) at a concentration of 60 mg/mL. Studies on the PEM (2:1) cream formulation revealed that it remained stable under room conditions. Skin irritation tests on rats showed no signs of oedema or erythema after treatment. Conclusion: The PEM with a ratio of (2:1) demonstrated optimal activity as an oxidative stress-neutralizing agent, inhibitor of enzymes responsible for skin aging and hyperpigmentation, and antibacterial agent. The cream formulation containing PEM exhibited physical stability and no detectable risk of skin irritation throughout the research procedures.

Safety Assessment on the Safety and Efficacy of an Additive of Endo-Β-1,4-Xylanase Produced by Komagataella ⁠phaffii CGMCC 7.371 (VTR-xylanase) as a Feed Additive for Weaned Piglets, Suckling Piglets, Minor Growing Porcine and All Avian Species (RP1039/1040)

An application was submitted to the Food Standards Agency in April 2021 from Victory Enzymes GmbH (‘the applicant’) for the new of authorisation of an additive (VTR-xylanase) containing endo-β-1,4-xylanase, under the category of ‘zootechnical additives’ and functional group ‘digestibility enhancers’. The additive is proposed to be used at an inclusion rate of 2000 U/kg for weaned piglets, suckling piglets, minor growing porcine species, laying hens and other laying birds, and at an inclusion rate of 1,000 U/kg for chickens for fattening and minor avian species. To support the Food Standards Agency (FSA) and Food Standards Scotland (FSS) in evaluating the dossier, the Advisory Committee on Animal Feedingstuffs (ACAF) were asked to review the dossier and the supplementary information from the applicant. The FSA/FSS concluded, based on the ACAF’s advice, that the additive was correctly characterised, and that it is stable for 12 months in its powder form when stored at 25°C, and for 18 months in its liquid form when stored at 5°C. The additive is stable at 70°C for 15 seconds during pelleting. Homogeneity in feed was also demonstrated. No further concerns were raised for section II of the dossier. The additive can be considered safe for the target species, consumers and the environment. The additive should be regarded as a skin sensitiser in both its powder and liquid form. The liquid form of the additive is not a skin irritant. In its powder form, the additive should be considered a potential skin irritant. The additive should be considered an irritant to the eyes in both forms. As an enzyme preparation, the additive should be considered a potential respiratory sensitiser. VTR-xylanase is efficacious for weaned piglets, suckling piglets, minor growing porcine species, laying hens and other laying birds at 2,000 U/kg, and in chickens for fattening and minor avian species at 1,000 U/kg. The views of ACAF have been taken into account in the safety assessment which represents the opinion of the FSA and FSS.

A Review on Topical Gels as Drug Delivery System

The skin serves as a formidable barrier to drug penetration, primarily due to the stratum corneum. For successful transdermal drug delivery, the drug must overcome this barrier and reach the target site in sufficient concentrations. Drug molecules can penetrate the skin via the transcellular, intercellular, and appendageal pathways. The extent of drug permeation is influenced by factors such as the physicochemical properties of the drug, the nature of the vehicle, and the condition of the skin. Gels, being hydrophilic, can enhance drug permeation by increasing the hydration of the stratum corneum. Permeation enhancers, which reversibly alter the structure of the stratum corneum, can also improve drug permeation. Recent advancements in topical gel drug delivery include the use of nanotechnology, stimuli-responsive gels, combination therapy, natural polymers, and biodegradable materials. The delivery of biomolecules through the skin remains a challenge, and strategies such as iontophoresis, microneedles, and nanocarriers are being investigated. 3D printing technology enables the personalized fabrication of gels with precise drug dosing and customized release profiles. Despite significant advancements, challenges such as limited drug permeability, potential for skin irritation, and the need for long-term stability studies persist. Future research should focus on developing innovative strategies to overcome these challenges and optimize the performance of topical gels, involving the exploration of new drug-polymer combinations, advanced drug delivery technologies, and in silico modeling tools

Computational study of novel natural agonists targeting farnesoid X receptor

The farnesoid X receptor (FXR) is a crucial therapeutic target for treating non-alcoholic steatohepatitis (NASH). Although obeticholic acid (OCA) as a FXR agonist presents good efficacy, the safety data such as severe pruritus should be carefully considered. To discover new medications, we screen and choose the optimal compounds from ZINC15 database that may agonistically interact with FXR. We utilized the DS19 software to assist us in conducting the computer-aided structure based virtual screening to discover potential FXR agonists. After LibDock scores were determined by screening, their absorption, distribution, metabolism, excretion and toxicity predictions were examined. To determine the binding affinity between the chosen drugs and FXR, molecule docking was utilized. Molecular dynamics simulation was utilized to evaluate the stabilization of the ligand-FXR complex in its native environment. Higher binding affinity and stability with FXR were observed for ZINC000013374322 and ZINC000006036327, as two novel natural compounds, with lower rodent carcinogenicity, Ames mutagenicity, no hepatotoxicity and non-inhibitors of CYP2D6. They could stably exist in the environment, possess favorable potential energy and exert pharmacological effects at lower doses. Furthermore, ZINC000006036327 had lower skin irritancy and sensitization potential compared to OCA, also suggest the possibility of improved skin itching occurrence. ZINC000013374322 and ZINC000006036327 were found to be the best leading compounds to be FXR agonists. They are chosen as safe candidates for FXR target medicine, which play comparable pharmacological effects at lower doses.

Evaluating the Efficacy and Safety of Alpha-Hydroxy Acids in Dermatological Practice: A Comprehensive Clinical and Legal Review.

The global market for alpha-hydroxy acids (AHAs) is undergoing significant expansion, propelled by increasing demand for skincare products that address aging and environmental damage. This review focuses on the dermatological applications of AHAs, particularly in cosmetic formulations like chemical peels. We have identified that AHAs, such as glycolic and lactic acids, enhance skin rejuvenation by promoting apoptosis in skin cells, boosting collagen and elastin synthesis, and improving skin texture and luminosity. Our comprehensive analysis reveals a nuanced understanding of AHAs' effectiveness across various skin types and conditions, demonstrating their broad utility in treating conditions like acne, hyperpigmentation, and photoaging. However, the optimal concentrations for therapeutic efficacy with minimal side effects are yet to be precisely defined, necessitating further research. Regulatory compliance is underscored as essential for the safe application of AHAs in cosmetics, with international guidelines recommending specific concentrations and pH levels to minimize potential skin irritation. In Conclusion, the review highlights the effectiveness of AHAs in cosmetic dermatology, emphasizing the necessity for continued research and rigorous regulatory adherence to maximize their safe and beneficial application worldwide.

Synthesis and Performance of Bio-Based Amphoteric Surfactants.

As the global surfactant market continues to expand, there is an increasing need to develop bio-based alternatives in the shift towards a circular economy. This study focuses on the synthesis of polar, amphoteric, amine-oxide surfactants starting from biomass-derived monosaccharides and demonstrating their potential in various applications. The synthesis involved a reductive amination of the sugars with an alkylamine and formaldehyde followed by oxidation to produce N-oxide surfactants. These bio-based surfactants exhibited promising properties, including high solubility, foamability, surface tension reduction, and critical micelle concentration. In particular, N-GalA1.10 and N-GalA1.12 showed comparable performance to commercial surfactants. Furthermore, these bio-based surfactants demonstrated significantly lower skin irritation potential when compared to petrochemical-derived counterparts like sodium laureth sulfate (SLES), making them potentially suitable for personal care products. The biodegradability assessment revealed that N-GalA1.12 exhibited good biodegradation, indicating its potential environmental compatibility. In conclusion, this study highlights the potential of bio-based N-oxide surfactants derived from monosaccharides as sustainable and skin-friendly alternatives to traditional amphoteric surfactants, like cocamidopropyl betaine (CAPB).

Discovery of (E)-3-(4-chlorophenyl)-N-(5-hydroxypentyl)acrylamide among N-substituted cinnamamide derivatives as a novel cosmetic ingredient for hyperpigmentation

Hyperpigmentation disorders may result from inappropriate melanin deposition and/or excessive melanin synthesis. They are classified mainly as aesthetic problems, but they can significantly affect human health by decreasing self-esteem. There are available only limited treatment options for hyperpigmentation disorder, among others, cosmetic products applied topically. Depigmenting ingredients were found to be ineffective and characterized by various side effects. As a result, many efforts are made to discover novel, potent, and safe melanogenesis inhibitors for possible use in topical cosmetic depigmenting formulations. Cinnamic acid derivatives constitute a widely tested group for that purpose. This article reports research in the group of N-alkyl cinnamamide derivatives (un)substituted in phenyl ring. Among tested series, (E)-3-(4-chlorophenyl)-N-(5-hydroxypentyl)acrylamide (compound 21) showed the most promising inhibitory properties in mushroom tyrosinase assay (IC50 = 36.98 ± 1.07 µM for monophenolase activity, IC50 = 146.71 ± 16.82 µM for diphenolase activity) and melanin production inhibition in B16F10 mouse melanoma cell line at concentration 6.25 µM resulting probably from decreasing of Tyr, Mitf, Tyrp-1, and Tyrp-2 genes expression. This compound also showed melanin production inhibitory properties in pigmented reconstructed human epidermis when used in 1 % and 2 % solutions in 50 % PEG400. In vitro evaluation of its safety profile showed no cytotoxicity to human keratinocytes HaCaT, human skin fibroblasts BJ, and human primary epidermal melanocytes HEMa, no mutagenicity in the Ames test, no genotoxicity in micronucleus test, no phototoxicity, as well as no skin irritation potential tested in PEG400 solution. This compound was also shown to penetrate across the epidermis to reach the possible site of action. The performed research led to classify (E)-3-(4-chlorophenyl)-N-(5-hydroxypentyl)acrylamide as a novel potential depigmenting cosmetic ingredient.

Creating, Developing, and Evaluating Herbal Lipstick Utilising “Beta Vulgaris”

Herbal lipsticks are made from natural ingredients like plant extracts and oils, often avoiding synthetic chemicals. They're popular for their nourishing properties and sometimes offer subtle tints. Beetroot extract is prized for its rich colour and potential benefits for the lips, like hydration and nourishment. The cosmetics industry is witnessing a paradigm shift towards natural and sustainable beauty products, driven by consumer demand for safer alternatives. In response, this study explores the formulation and evaluation of herbal lipstick utilising Beta Vulgaris, commonly known as beetroot, as a natural colourant. Beetroot extract, rich in betacyanins, not only imparts vibrant hues but also offers potential skincare benefits due to its antioxidant properties. This report outlines the formulation process, detailing the extraction of colourant from Beta Vulgaris and its integration into lipstick bases. Through the exploration of Beta Vulgaris as a natural colourant for herbal lipstick formulations, this research contributes to the advancement of natural cosmetics and underscores the potential of plant-based ingredients in meeting the growing demand for clean beauty products. Herbal lipstick formulations typically include a combination of pigments, perfumes, waxes, preservatives, antioxidants, oils, and colours. The advantages of herbal lipstick lie in its safety, cost- effectiveness, non-toxicity, and utilisation of pigments sourced from readily available plants and vegetables. Given the prevalence of side effects associated with synthetic formulations, this study sought to develop and evaluate herbal lipstick formulations using natural colourants. The evaluation parameters included colour intensity, pH levels, skin irritation potential, perfume stability, solubility, surface anomalies, and ageing stability. The findings of this study indicate that herbal lipstick formulations utilising natural colourants exhibit fewer or no side effects compared to synthetic alternatives. Furthermore, they have the potential to enhance consumer acceptance due to the incorporation of diverse natural ingredients and harmless colourants.

Preclinical development of ATR04-484, an auxotrophic strain of Staphylococcus epidermidis, for the topical treatment of epidermal growth factor receptor (EGFR) inhibitor-induced dermal toxicity.

e24074 Background: Agents targeting the EGFR-mediated signaling pathway are commonly used for the treatment of advanced lung, pancreatic, colorectal, and head and neck cancers. Significant dermal toxicities, which occur in up to 90% of patients treated with EGFR inhibitors (EGFRis) and other therapies inhibiting downstream signaling pathways, may be disruptive to a patient’s quality of life and adherence to therapy. Inhibition of the EGFR pathway may suppress host defenses and lead to opportunistic pathogenic colonization or infection. EGFRi-induced dermal toxicity is associated with elevated levels of Staphylococcus aureus and IL-36γ. ATR04-484 is a topical ointment containing S. epidermidis strain SE484, isolated from a healthy human volunteer that was selected for its ability to inhibit S. aureus and IL-36γ . Methods: Reconstructed human epidermis (RHE) and ex vivo pig skin were used to measure the effect of ATR04-484 on S. aureus in therapeutic and prophylactic settings with S. aureus added prior to or after ATR04-484, respectively. To evaluate the anti-inflammatory effects of ATR04-484, IL-36γ levels were measured on untreated RHE and RHE treated with erlotinib alone or in combination with ATR04-484. 104 colony-forming units (CFU) of methicillin-resistant (MRSA) or methicillin-sensitive (MSSA) S. aureus were used. Toxicology was assessed by measuring cell viability in three in vitro toxicology assays: the eye irritant potential was tested on 3D reconstituted human cornea-like epithelium (RhCE), the skin irritant potential of the strain in the ointment was assessed on 3D RHE, and the skin corrosive potential was evaluated on RHE. Results: ATR04-484 comparably inhibited growth of both MRSA and MSSA in therapeutic and prophylactic settings. In a therapeutic setting, ATR04-484 inhibited MRSA growth by 1 log (90%) compared to untreated MRSA in both RHE and pig skin. In a prophylactic setting, ATR04-484 inhibited MRSA growth by approximately 5 logs on RHE and 2 logs on pig skin. Additionally, application of ATR04-484 reduced IL-36γ to a level comparable to untreated RHE. The effect was dose-dependent; application of 109CFU/cm2 of ATR04-484 showed more potent IL-36γ reduction compared to 108 CFU/cm2. The three toxicology assays indicate that ATR04-484 does not cause irritation or corrosion. Conclusions: In these preclinical studies, ATR-04-484 showed a promising preclinical profile for the treatment of EGFRi-induced dermal toxicity by significantly reducing S. aureus growth, completely ameliorating IL-36γ levels, and showing no safety concerns.

Herbal Innovations in Eczema Care: A Comprehensive Review of Formulation Development, Safety, and Efficacy

Eczema, also known as atopic dermatitis, presents a significant challenge in clinical management due to its multifactorial etiology and variable clinical manifestations. Conventional treatments often focus on symptom relief and inflammation control, yet concerns regarding their long-term safety and efficacy persist. In recent years, there has been growing interest in exploring herbal therapies as adjunctive or alternative treatments for eczema management. This review aims to provide a comprehensive overview of the development and evaluation of topical herbal formulations specifically targeted at managing infectious eczema. Beginning with an introduction to eczema, encompassing its prevalence, underlying pathophysiology, and conventional treatment modalities, the review sets the stage for exploring the potential of herbal therapies. It delves into the significance of herbal treatments in eczema care, emphasizing their potential advantages such as efficacy, safety, and patient acceptability. The review then outlines the systematic approach to formulation development, encompassing the selection of herbal ingredients, optimization of base formulations, and rigorous stability testing. Safety evaluation strategies, including toxicological assessments, skin irritation potential, and allergenicity testing, are discussed to ensure the safety and tolerability of the herbal formulations. Efficacy evaluation involves assessing anti-inflammatory properties, antimicrobial activity, and conducting well-controlled clinical trials to determine their clinical efficacy and impact on patient outcomes. Through a comprehensive discussion and analysis, this review aims to elucidate the potential of topical herbal formulations as promising therapeutic options for managing infectious eczema, while also identifying areas for further research and optimization

The application of PTR-MS and non-targeted analysis to characterize VOCs emitted from a plastic recycling facility fire.

On April 11th, 2023, the My Way Trading (MWT) recycling facility in Richmond, Indiana caught fire, mandating the evacuation of local residents and necessitating the U.S. Environmental Protection Agency (EPA) to conduct air monitoring. The EPA detected elevated levels of plastic combustion-related air pollutants, including hydrogen cyanide and benzene. We aimed to identify these and other volatile organic compounds (VOCs) present as well as to identify the potential hazard of each compound for various human health effects. To identify the VOCs, we conducted air monitoring at sites within and bordering the evacuation zone using proton transfer reaction mass spectrometry (PTR-MS) and non-targeted analysis (NTA). To facilitate risk assessment of the emitted VOCs, we used the EPA Hazard Comparison Dashboard. We identified 46 VOCs, within and outside the evacuation zone, with average detection levels above local background levels measured in Middletown, OH. Levels of hydrogen cyanide and 4 other VOCs were at least 1.8-fold higher near the incidence site in comparison to background levels and displayed unique temporal and spatial patterns. The 46 VOCs identified had the highest hazardous potential for eye and skin irritation, with approximately 45% and 39%, respectively, of the VOCs classified as high and very high hazards for these endpoints. Notably, all detected VOC levels were below the hazard thresholds set for single VOC exposures; however, hazard thresholds for exposure to VOC mixtures are currently unclear. This study serves as a proof-of-concept that PTR-MS coupled with NTA can facilitate rapid identification and hazard assessment of VOCs emitted following anthropogenic disasters. Furthermore, it demonstrates that this approach may augment future disaster responses to quantify additional VOCs present in complex combustion mixtures.

Micellar extracts obtained from Bistortae rhizoma, Fraxinus excelsior, and Romex crispus as components of hair shampoos

Abstract The aim of the present study was to evaluate the potential applications of micellar extracts derived from Bistortae rhizoma, Fraxinus excelsior, and Romex crispus as components of hair shampoos and to examine the impact of these micellar extracts on the specific properties of the formulated cosmetics. The antioxidant activity, polyphenol content, and vitamin C content of the plant materials selected for the study were assessed. In addition, particle size analysis was performed for the obtained micellar extracts. The shampoos prepared on the basis of original formulations were evaluated for irritation potential, viscosity, foam stability index, and color. The plants evaluated in the study exhibited a high level of antioxidant activity, and the derived extracts were found to contain micellar aggregates. The application of the extracts was shown to reduce the skin irritation potential of the shampoos and reduce their viscosity. In addition, the formulated shampoos were characterized by a high foam stability index. Substantial variations in the color of the cosmetics were observed upon the introduction of the micellar extracts into the formulations.

Comparative toxicological analysis of two pristine carbon nanomaterials (graphene oxide and aminated graphene oxide) and their corresponding degraded forms using human in vitro models

Despite the wide application of graphene-based materials, the information of the toxicity associated to some specific derivatives such as aminated graphene oxide is scarce. Likewise, most of these studies analyse the pristine materials, while the available data regarding the harmful effects of degraded forms is very limited. In this work, the toxicity of graphene oxide (GO), aminated graphene oxide (GO-NH2), and their respective degraded forms (dGO and dGO-NH2) obtained after being submitted to high-intensity sonication was evaluated applying in vitro assays in different models of human exposure. Viability and ROS assays were performed on A549 and HT29 cells, while their skin irritation potential was tested on a reconstructed human epidermis model. The obtained results showed that GO-NH2 and dGO-NH2 substantially decrease cell viability in the lung and gastrointestinal models, being this reduction slightly higher in the cells exposed to the degraded forms. In contrast, this parameter was not affected by GO and dGO which, conversely, showed the ability to induce higher levels of ROS than the pristine and degraded aminated forms. Furthermore, none of the materials is skin irritant. Altogether, these results provide new insights about the potential harmful effects of the selected graphene-based nanomaterials in comparison with their degraded counterparts.

Assessment of the feed additive consisting of Pediococcus pentosaceusDSM 23689 for all animal species for the renewal of its authorisation (Chr. Hansen A/S).

Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the assessment of the application for renewal of the authorisation of Pediococcus pentosaceus DSM 23689 as a technological additive, silage additive for all animal species. The applicant has provided evidence that the additive currently on the market complies with the existing conditions of authorisation. The Panel concluded that the additive remains safe for all animal species, consumers, and the environment under the authorised conditions of use. Regarding user safety, the additive should be considered as a respiratory sensitiser. No conclusions can be drawn on the skin sensitisation, and skin and eye irritancy potential of the additive. There is no need for assessing the efficacy of the additive in the context of the renewal of the authorisation.

One-Pot Synthesis of a Robust Crosslinker-Free Thermo-Reversible Conducting Hydrogel Electrode for Epidermal Electronics.

Traditional epidermal electrodes, typically made of silver/silver chloride (Ag/AgCl), have been widely used in various applications, including electrophysiological recordings and biosignal monitoring. However, they present limitations due to inherent material mismatches with the skin. This often results in high interface impedance, discomfort, and potential skin irritation, particularly during prolonged use or for individuals with sensitive skin. While various tissue-mimicking materials have been explored, their mechanical advantages often come at the expense of conductivity, resulting in low-quality recordings. We herein report the facile fabrication of conducting and stretchable hydrogels using a "one-pot" method. This approach involves the synthesis of a natural hydrogel, termed Golde, composed of abundant and eco-friendly components, including gelatin, chitosan, and glycerol. To enhance the conductivity of the hydrogel, various conducting materials, such as poly(3,4-ethylenedioxythiophene) polystyrenesulfonate (PEDOT:PSS), thermally reduced graphene (TRG), and MXene, are introduced. The resulting conducting hydrogels exhibit remarkable robustness, do not require crosslinkers, and possess a unique thermo-reversible property, simplifying the fabrication process and ensuring enhanced long-term stability. Moreover, their fabrication is sustainable, as it employs environmentally friendly materials and processes while retaining their skin-friendly characteristics. The resulting hydrogel electrodes were tested for electrocardiogram (ECG) signal acquisition and outperformed commercial electrodes even when implemented in an all-flexible electrode setup simply using copper tape, owing to their inherent adhesiveness.

A Review of the Diagnostic and Therapeutic Gaps in Rosacea Management: Consensus Opinion.

Rosacea is a common, chronic inflammatory disease characterized by both fluctuating and fixed heterogeneous signs such as facial erythema, papules/pustules, telangiectasia, acute vasodilation (flushing), and phymatous changes, and symptoms such as cutaneous stinging and burning. The shift to a phenotype-based approach to rosacea management has improved the consistency of recommendations across recent published guidelines. Consistent and thorough guidance for the classification, diagnosis, and management of the disease is difficult, as the mechanisms underlying the development of rosacea are still not completely understood nor universally accepted. Here, we provide a critical review of current published guidance, and gaps in the knowledge and management of rosacea. We present the recently approved microencapsulated benzoyl peroxide as an effective topical treatment option for papulopustular rosacea. Benzoyl peroxide (BPO) has been used in acne management for many years; however, many clinicians perceive treatment of rosacea with any BPO formulation to be counterintuitive because of concerns of potential skin irritation, while the lack of an accepted mechanism of action on rosacea pathophysiology means that others may be hesitant to use BPO as a treatment. Minocycline foam 1.5% is also an option for the treatment of inflammatory lesions in rosacea, with a decreased risk of systemic adverse events compared with oral minocycline.